
BBIO Market Capitalization Overview
Market Cap: $7.53B as of Jun 12, 2025
$7.53B
Past Month+$753.83M (11.13%)
As of Jun 12, 2025, BBIO has a market capitalization of $7.53B. Over the past 30 days, its market cap has decreased by -7.64%, while in the last 12 months, it has increased by 45.18%.
Market capitalization represents the total value of BridgeBio Pharma Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BBIO Market Cap Formula = Stock Price * Shares Outstanding
The market cap of BBIO helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of BridgeBio Pharma Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
BBIO Market Cap Formula = Stock Price * Shares Outstanding
The market cap of BBIO helps investors assess the company's size and compare it with competitors for better investment decisions.
BBIO Market Cap & Key Trends
See BridgeBio Pharma Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in BBIO
Order type
Buy in
Order amount
Est. shares
0 shares
BBIO Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $6.74B | -7.64% |
May 1, 2025 | $7.30B | +16.09% |
Apr 1, 2025 | $6.29B | +0.03% |
Mar 3, 2025 | $6.28B | +7.06% |
Feb 3, 2025 | $5.87B | +10.04% |
Jan 2, 2025 | $5.33B | +6.02% |
BBIO End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $7.53B | +45.18% |
2024 | $5.19B | -26.16% |
2023 | $7.03B | +516.56% |
2022 | $1.14B | -53.60% |
2021 | $2.46B | -71.86% |
2020 | $8.73B | — |
FAQs About BridgeBio Pharma Inc (BBIO) Market Cap
As of Jun 12, 2025, the market capitalization of BBIO is $7.53B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, BridgeBio Pharma Inc’s market capitalization has increased by 11.13%, changing from $6.78B to $7.53B as of Jun 12, 2025.
In the last 3 months, BridgeBio Pharma Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, BridgeBio Pharma Inc’s market capitalization decreased from $7.03B in January to $5.19B in December, reflecting a -26.16% change.
In the past five years, BBIO has had a compound annual growth rate (CAGR) of -9.88% in market capitalization. This means its market cap has shrunk at an average rate of -9.88% per year.